Parenteral Drug Association
 | |
| Abbreviation | PDA |
|---|---|
| Formation | 1946 |
| Founders | Group of pharmaceutical manufacturers |
| Type | Nonprofit trade association |
| Legal status | Trade association |
| Purpose | Coordinator of science, technology, and regulatory information for pharmaceutical industry |
| Location | |
Region served | Worldwide |
| Services | Advocacy and information for the pharma industry |
President | Glenn Wright |
| Affiliations | PDA Foundation for Pharmaceutical Education, Training and Research (PDAF) |
| Funding | Members fees |
| Website | www |
The Parenteral Drug Association (PDA) is an international non-profit industry trade group for pharmaceutical and biopharmaceutical manufacturers. The PDA aims to provide scientifically sound, practical technical information and expertise to advance pharma manufacturing science and regulation.[1][2]
The PDA also runs special interest groups where pharmaceutical manufacturers share information, experiences and best practices relating to pharmaceutical manufacturing.[3]
History
The PDA was founded in 1946 as the Parenteral Drug Association by a small group of pharmaceutical manufacturers who recognized the need for an organization to disseminate technical information within the industry, it grew to have more than 11,000 members worldwide.[4]
Structure
The association is split into regional chapters and has members in 74 countries and regions including Africa, Asia Pacific, Europe, North America and South America.
References
- ^ "Parenteral Drug Association (PDA)". European Pharmaceutical Review. Retrieved August 14, 2025.
- ^ "Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show". Reuters. October 5, 2024.
- ^ "The turning tides of endotoxin tests". ACS Publications. October 28, 2024.
- ^ "About PDA". Parenteral Drug Association. Retrieved 8 October 2015.